<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04494295</url>
  </required_header>
  <id_info>
    <org_study_id>C-MIRROR-001</org_study_id>
    <nct_id>NCT04494295</nct_id>
  </id_info>
  <brief_title>The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation</brief_title>
  <acronym>MIRROR</acronym>
  <official_title>The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Integra LifeSciences Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oculus Imaging LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Integra LifeSciences Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry will study the use of the Aurora® Surgiscope to provide surgical access and&#xD;
      visualization in minimally invasive removal of hematoma in the brain. Many methods of&#xD;
      hematoma removal are available and will be based on surgeon preference. The impact of patient&#xD;
      selection and time to surgery from last known well time will be explored.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 23, 2020</start_date>
  <completion_date type="Anticipated">October 15, 2029</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2028</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Surgical Success</measure>
    <time_frame>During surgical procedure to evacuate supratentorial intracerebral hemorrhage</time_frame>
    <description>Rate of surgical success defined as reduction to &lt; 15 cc total volume of the supratentorial intracerebral hemorrhage on immediate Post-op CT Scan</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Supratentorial Hemorrhage</condition>
  <arm_group>
    <arm_group_label>AURORA</arm_group_label>
    <description>Aurora® Surgiscope used for MIS evacuation of supratentorial hematoma</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Aurora Surgiscope System</intervention_name>
    <description>MIS evacuation of hematoma using the Aurora Surgiscope System</description>
    <arm_group_label>AURORA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        general population with an acute, spontaneous, primary, supratentorial ICH&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject Age is &gt; 18&#xD;
&#xD;
          -  Subject with a Head CT that demonstrates an acute, spontaneous, primary,&#xD;
             supratentorial ICH of volume &gt; 20 mL, assessed via standard of care techniques&#xD;
&#xD;
          -  Subject Surgery can be initiated within 12 hours of the last known well time or, in&#xD;
             patients with wake-up onset, within 12 hours of the time the patient awoke with&#xD;
             symptoms.&#xD;
&#xD;
          -  Subject has a NIHSS score &gt; 5&#xD;
&#xD;
          -  Subject has a baseline Modified Rankin Scale (mRS) Score ≤ 2&#xD;
&#xD;
          -  Subject with a CT Angiography demonstrating no vascular malformation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has an underlying vascular lesion defined as causative source of ICH&#xD;
&#xD;
          -  Subject has a profound neurological deficit defined as fixed/dilated pupils or&#xD;
             bilateral extensor motor posturing&#xD;
&#xD;
          -  Subject has an Infratentorial or brainstem ICH&#xD;
&#xD;
          -  Subject has a known life expectancy &lt; 6 months&#xD;
&#xD;
          -  Subject has an uncorrectable coagulopathy&#xD;
&#xD;
          -  Subject has a mechanical heart valve&#xD;
&#xD;
          -  Subject is pregnant&#xD;
&#xD;
          -  Subject participates in another concurrent interventional clinical trial&#xD;
&#xD;
          -  Subject who is unable to meet study follow-up requirements&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sigmund Kulessa, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Integra LifeSciences Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joshua Dilworth</last_name>
    <phone>+1 609 789-2310</phone>
    <email>Joshua.Dilworth@integralife.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCLA Ronald Regan Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Georffrey Colby, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bart Jacher</last_name>
    </contact>
    <investigator>
      <last_name>Richard Crowley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leo Gallagher</last_name>
    </contact>
    <investigator>
      <last_name>Justin Singer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University in St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bridgette Vaugh</last_name>
    </contact>
    <investigator>
      <last_name>Joshua Osbun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University at Buffalo</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Gay</last_name>
    </contact>
    <investigator>
      <last_name>Adnan Siddiqui, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn school of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Smeck</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lauren Todd</last_name>
    </contact>
    <investigator>
      <last_name>Mark Bain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Minh Dieu</last_name>
      <email>minh.dieu@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Brian Jankowitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prisma Health - Upstate</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandon Brown</last_name>
    </contact>
    <investigator>
      <last_name>Raymond Turner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington - Harborside</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jad Keen</last_name>
    </contact>
    <investigator>
      <last_name>Mark Levitt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 28, 2020</study_first_submitted>
  <study_first_submitted_qc>July 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2020</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

